Effect of Exercises on Physical Health and Cardiorespiratory Fitness in Obese Women

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05618899
Collaborator
(none)
50
1
2
9.7
5.2

Study Details

Study Description

Brief Summary

The study will be a Randomized clinical trial and will be conducted in services hospital lahore. The sample size of 50 patients will be taken in this study to find the effects of high intensity interval training versus moderate intensity exercises on physical health and cardiorespiratory fitness in obese women.

Patients will be divided into two groups (Group A will be treated with high intensity interval training and Group B will be treated with moderate intensity exercises). Eligible participants attended three session per week. Overnight fast, resting metabolic rate and blood pressure will be assessed. An oral glucose test will be assessed and baseline blood samples will be used for lipoprotein analysis. Pacer test and step test performed in the each session. A regular follow-up visits to department and a final assessment will be made at the end of last week by using questionnaire and resulting improvement will shown in results after completion. Data will be analyzed on SPSS 25.

Condition or Disease Intervention/Treatment Phase
  • Other: HIGH INTENSITY INTERVAL TRAINING
  • Other: MODERATE INTENSITY EXERCISE
N/A

Detailed Description

The study will be a Randomized clinical trial and will be conducted in services hospital lahore. The study will be completed within the duration of ten months. Non probability convenient sampling study technique will be used to collect the data. The sample size of 50 patients will be taken in this study to find the effects of high intensity interval training versus moderate intensity exercises on physical health and cardiorespiratory fitness in obese women.

Patients will be divided into two groups (Group A will be treated with high intensity interval training and Group B will be treated with moderate intensity exercises). Eligible participants attended three session per week. Overnight fast, resting metabolic rate and blood pressure will be assessed. An oral glucose test will be assessed and baseline blood samples will be used for lipoprotein analysis. Pacer test and step test performed in the each session. A regular follow-up visits to department and a final assessment will be made at the end of last week by using questionnaire and resulting improvement will shown in results after completion. Data will be analyzed on SPSS 25.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Effect oh High Intensity Interval Training Versus Moderate Intensity Exercises on Physical Health and Cardiorespiratory Fitness in Obeses Women
Actual Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Feb 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: HIGH INTENSITY INTERVAL TRAINING

High intensity interval training basicaaly short bursts of intense exercise alternating with low intensity recovery periods. Training should be done on treadmill for 25-30 minutes.. Training proceed for 1 month once a day

Other: HIGH INTENSITY INTERVAL TRAINING
Training should be done on treadmill for 25-30 minutes.. Training proceed for 1 month once a day

Experimental: MODERATE INTENSITY EXERCISE

moderate intensity exercises consist of generally 30-60 minutes of aerobic exercises at 64-76% of peak heart rate. Training should be done on treadmill for 30-60 minutes. Training proceed for 1 month once a day

Other: MODERATE INTENSITY EXERCISE
moderate intensity exercises consist of generally 30-60 minutes of aerobic exercises at 64-76% of peak heart rate. Training should be done on treadmill for 30-60 minutes. Training proceed for 1 month once a day

Outcome Measures

Primary Outcome Measures

  1. Step test [4weeks]

    the step test is designed to measured a person's aerobic fitness. Participants steps up and down, on and off, an aerobics- type step for three minutes to increase heart rate and to evaluate the heart's recovery rate during the minute immediately following the step test exercise.

  2. Glucose tolerance test [4weeks]

    The glucose tolerance test is a medical test in which glucose is given and blood samples taken afterward to determine how quickly it is cleared from the blood. The test is usually used to test for diabetes, insulin resistance. an oral glucose tolerance test (OGTT), a standard dose of glucose is ingested by mouth and blood levels are checked two hours later.

  3. Lipoprotein blood test: [4weeks]

    lipoprotein test measures the level of lipoprotein in your blood. Lipoproteins are substances made of protein and fat that carry cholesterol through your bloodstream. Lipoprotein (a) is a type of LDL (bad) cholesterol. A high level of lipoprotein (a) may mean you are at risk for heart disease.

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women between the ages of 17-30 years

  • BMI 25-35kg/m2.

  • Sedentary (< 30 minutes of structured activity per week)

  • Normal glucose tolerance ( fasting glucose <100mg/dL)

  • No use of medications known to affect body composition or metabolism

  • All participants will be non smoker

  • No MI history

  • No previous surgery.

  • Free from known injury or known clinical conditio

Exclusion Criteria:
  • BMI < 30 kg/m2 Known clinical condition including family history of sudden death, uncontrolled hypertension, type 1 and type 2 diabetes and cardiovascular diesease. • Participants will be excluded if they report in competitive exericise

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ittefaq Hospital Lahore Punjab Pakistan 54000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: madiha younas, MS, riphah internationl university

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05618899
Other Study ID Numbers:
  • REC/22/0343 MAHAM ATHAR
First Posted:
Nov 16, 2022
Last Update Posted:
Jan 25, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University

Study Results

No Results Posted as of Jan 25, 2023